Latest Updates
Second Quarter 2010 Targets in Oncology Updates and Additions
- Anaplastic lymphoma kinase (ALK)
- B-cell CLL/lymphoma 6 (BCL6)
- Bromo adjacent homology domain-containing protein 1 (BAHD1)
- CD38
- Cyclin-dependent kinase (Cdk) family
- Echinoderm microtubule associated protein like 4 (EML4)
- Excision repair cross-complementing rodent repair deficiency, complementation group 1 (ERCC1)
- Gonadotropin-releasing hormone receptor (GnRHr)
- Hedgehog (Hh) signaling pathway
- Insulin-like growth factor (IGF)
- Insulin receptor substrate 1 (IrS1)
- Interferon regulatory factor 3 (IRF3)
KDM1A
- Mammalian target of rapamycin (mTOR)
- Neuropilin 1 (NRP1, NRP-1)
- Neuropilin (NRP)
- Polycomb group ring finger 4 (PCGF4)
- Ret proto-oncogene (RET)
- Serine/threonine kinase 33 (STK33)
|
|
NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE: 1-949-830-0448 FAX: 1-949-830-0887
INFO@NEWMEDINC.COM
|